Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CHA, Sorrento JV Highlights Korean Immuno-Oncology Appetite

Executive Summary

Sorrento and CHA Biotech’s agreement to form a CAR-NK cell therapy joint venture is very much “on trend”, being the latest in a recent series of immuno-oncology collaborations between Korean and foreign firms and indicating a rapidly growing appetite for assets in the field.

Advertisement

Related Content

Deal Watch: Roche Aborts But Regeneron, Amgen and Pfizer Sign Up
Korean Stem Cell Ventures Pursuing Divergent R&D Strategies

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register